NCT06147999Recruiting
Impact of a Biophoton Therapy on Patients With Brain Disorders
Source: ClinicalTrials.gov · Last updated 8 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 14 Nov 2023
- Start date
- 8 Nov 2023
- Primary completion date
- 8 Nov 2026
- Lead sponsor
- First Institute of All Medicines
- Diseases
- Alzheimer disease, Parkinson disease
- NCT number
- NCT06147999
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 8 Nov 2023 to the primary completion date, 8 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Is participating in another investigational drug or device trial.
Other illness
- Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
- Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
- Has an active infectious disease, such as COVID-19.
Other
- Someone that relies on a ventilator.
- Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
- Pregnant women.
Who the study is looking for
- Must meet conditions for approval.
- Must be 18-years or older and stay in a hotel.
- Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
- Can provide informed consent or can be assisted by caregiver.
- Can provide a clinical diagnosis of a brain disorder.
- Can complete all study procedures during the study.
- Must be fluent in English (or the Caregiver can fully translate).
- Women of childbearing age must provide results of a pregnancy test in order to participate.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001 Coordinator of this site? Confirm its status | Butler | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.